Schedule 13D ownership disclosure

RECURSION PHARMACEUTICALS INC CL A

Security class unavailable · CUSIP: 75629V104

Event date: 2021-11-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,740,917
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-21-010774
Form type
SC 13D/A
Filer
Mubadala Investment Co PJSC
CIK
CIK 1704268
Filed
Nov 04, 2021
Reporting period
Nov 01, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub